SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Addition of New Sub-Studies to Existing Clinical Collaboration with GlaxoSmithKline Evaluating Nirogacestat in Combination with BLENREP in Patients with Relapsed or Refractory Multiple Myeloma

NEXT STORY
Sharps Compliance Reports Fiscal 2022 First Quarter Results
PREV STORY
Medical Laser Market to Reach $4.32 Billion by 2028 – Exclusive Report by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The global plasma fractionation market size is projected to reach USD 39.5 billion by 2025 from USD 28.6 billion in 2020, at a CAGR of 6.7%

author_avatar
NASDAQ Market News

REMINDER: Moleculin Announces Conference Call to Discuss Recent Breakthrough Discovery and FDA Filing on Wednesday, December 12, 2018

HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or ...

author_avatar
NASDAQ Market News

Global DNA Probes-Based Diagnostics Markets, 2015-2022 – Focus on Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics & Others

Dublin, May 23, 2018 (GLOBE NEWSWIRE) -- The "DNA Probes-Based Diagnostics - Global Strategic ...

author_avatar
NASDAQ Market News